Potential strategies for combating COVID-19

Arch Virol. 2020 Nov;165(11):2419-2438. doi: 10.1007/s00705-020-04768-3. Epub 2020 Aug 10.

Abstract

Coronavirus disease 2019, also known as COVID-19, is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has now catapulted into a full-blown pandemic across the world, which has affected more than 2 million people and has led to approximately 150,000 fatalities all over the world (WHO). In this review, we elaborate all currently available data that shed light on possible methods for treatment of COVID-19, such as antiviral drugs, corticosteroids, convalescent plasma, and potentially effective vaccines. Additionally, ongoing and discontinued clinical trials that have been carried out for validating probable treatments for COVID-19 are discussed. The review also elaborates the prospective approach and the possible advantages of using convalescent plasma and stem cells for the improvement of clinical symptoms and meeting the demand for an instantaneous cure.

Publication types

  • Review

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Amides / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity
  • COVID-19
  • COVID-19 Serotherapy
  • COVID-19 Vaccines
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / pathology
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / therapy
  • Coronavirus Infections / virology
  • Cytokine Release Syndrome / immunology
  • Cytokine Release Syndrome / prevention & control*
  • Cytokine Release Syndrome / virology
  • Drug Combinations
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunization, Passive / methods
  • Immunologic Factors / therapeutic use*
  • Indoles / therapeutic use
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Lopinavir / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / pathology
  • Pneumonia, Viral / virology
  • Pyrazines / therapeutic use
  • Ritonavir / therapeutic use
  • SARS-CoV-2
  • Severity of Illness Index
  • Viral Vaccines / administration & dosage

Substances

  • Adrenal Cortex Hormones
  • Amides
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • COVID-19 Vaccines
  • Drug Combinations
  • Immunologic Factors
  • Indoles
  • Interleukin 1 Receptor Antagonist Protein
  • Pyrazines
  • Viral Vaccines
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • remdesivir
  • Adenosine Monophosphate
  • Hydroxychloroquine
  • umifenovir
  • favipiravir
  • tocilizumab
  • sarilumab
  • Ritonavir
  • Alanine